Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid tests may not be needed for all vitiligo and alopecia areata patients unless thyroid disease symptoms appear.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Baricitinib was effective in treating both early and late onset alopecia areata.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

A specific gene change is linked to severe hair loss.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Autoimmune reactions may cause both alopecia areata and HAM.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.